#United States #Indianapolis #Morgan Stanley #Eli Lilly #Global Healthcare

Eli Lilly Set to Participate in Morgan Stanley's 24th Annual Global Healthcare Conference

Eli Lilly and Company (NYSE: LLY), a renowned leader in biopharmaceutical innovations, has announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference scheduled for September 14, 2026. The event will feature a critical dialogue led by Ilya Yuffa, who serves as the executive vice president and president of Lilly USA and Global Customer Capabilities.

Overview of the Event

Date: September 14, 2026
Time: 1:50 PM Eastern Time
* Format: Fireside chat

During this engaging session, Ilya Yuffa will elaborate on Eli Lilly's ongoing research and development initiatives aimed at addressing some of the most pressing health issues affecting global populations today. The live audio webcast will be accessible on Lilly's investor website at Lilly Investor Relations. Furthermore, a replay of the discussion will be available for roughly 90 days following the conference for those who wish to revisit the insights shared.

About Eli Lilly

For 150 years, Eli Lilly has been at the forefront of pharmaceutical innovation, transforming scientific discoveries into actionable health solutions that enhance the quality of life for people around the world. The company specializes in a broad range of medical fields and integrates the latest advancements in biotechnology, genetics, and chemical research in its drug development processes. Eli Lilly's commitment to pioneering new treatments has made significant impacts on the following fronts:

• - Diabetes Management: Developing breakthrough medications that help individuals manage diabetes more effectively.
• - Obesity Treatment: Pioneering advancements that combat obesity and mitigate its far-reaching effects.
• - Alzheimer's Disease: Contributing to the ongoing fight against Alzheimer's with innovative research and medicines.
• - Immune Disorders: Providing new therapeutic options for individuals suffering from complex immune system issues.
• - Oncology Solutions: Revolutionizing cancer treatment to ease the burden on affected patients, bringing the promise of manageable diseases closer to reality.

In its relentless march towards a healthier future, Eli Lilly not only champions innovative clinical trials but also strives to mirror the rich diversity of the communities it serves. The company is dedicated to ensuring that its medicines remain accessible and affordable for all, showcasing a deep-seated commitment to health equity.

Educational Resources

For further information about Eli Lilly and its contributions to global health, visit Lilly.com and Lilly News. Additionally, join their community on social media platforms including Facebook, Instagram, and LinkedIn to stay updated on their latest activities and initiatives.

This year's conference presents not only an opportunity for a thought-provoking dialogue but also a chance for stakeholders to come together and discuss the evolving landscape of healthcare. Eli Lilly’s active participation underscores its commitment to leading transformative changes in the medical field, pushing the boundaries in search of innovative health solutions that truly make a difference.